Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using ,,, an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier ,,, Software Package
Mark R. Kagan 1 Julian Phillips 2 Carrie Liu 3 1Thermo Finnigan Piscataway NJ; 2Thermo Finnigan San Jose CA; 3Eisai Research Institute Andover MA Chemical Structure Validation The data presented here can be ac
Mark R. Kagan
1, Julian Phillips
2,
Carrie Liu
3
1Thermo Finnigan, Piscataway, NJ;
2Thermo Finnigan, San Jose, CA;
3Eisai Research Institute, Andover, MA
Chemical Structure Validation
The data presented here can be acquired using the Thermo Finnigan LCQ Series
of ion trap mass spectrometers
Introduction
With the high cost of bringing new drugs to market, the number of candidates
a pharmaceutical company can develop is limited. Most are using increasingly
sophisticated screening techniques to eliminate poor candidates early in
the discovery process. To be successful, properties such as the adsorption,
distribution, metabolism, excretion and toxicity of compounds, their metabolites
and impurities must be assessed quickly and accurately to characterize potential
lead compounds.
High-throughput analysis of impurities is particularly challenging at the
low sample concentrations typical in biological matrices. The wide range
of possible modifications further complicates data interpretation. With
inherent high sensitivity, selectivity, and sophisticated Data Dependent
operational capabilities, the Thermo Finnigan LCQ Series of ion trap mass
spectrometers are well suited for applications involving impurities.
Rapid acquisition, interpretation and analysis of structural data is crucial
for maintaining a compound screening process capable of working in a combinatorial
environment. Mass Frontier, Thermo Finnigans pioneering software package
for interpretation and management of mass spectra, can be configured to
automatically predict fragmentation pa
'"/>Source:
Page: All 1 2 3 4 5 6 7 8 9 Related biology technology :1.
Practical Applications of HyperDSC in a Pharmaceutical Laboratory2.
World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition3.
Low Abundance cDNA Cloned Using Stratagenes Human Universal
cDNA Library4.
Oil-Free PCR Using the Hot Top Assembly5.
Functional Cloning Using
ViraPort Retroviral cDNA Expression Libraries6.
Signal Transduction Reporting Systems Using Cis-Acting Enhancer
Elements7.
Using XL1-Red Mutator Strain to Generate Esterase Variants8.
Detect Released Oligosaccharides Using the Eagle Eye II
Still Video Imaging System9.
Comparison of Growth Techniques and Media for the Purpose of Plasmid
Isolation from E. coli Using the Eppendorf
Perfectprep Plasmid Mini
Kit10.
Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood
Mini Kit11.
Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood
Mini Kit
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCal...alcompanyfocusedondevelopingandcommercializingnove...DiTonno,PresidentandChiefExecutiveOfficer,isschedu...onference,tobeheldDecember1-2,2009atTheNewYorkPala...enGhiglieri,ChiefFinancialOfficer,willbeavailablet...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
(Date:11/24/2009)...,, REDWOODCITY,Calif.,Nov.24/PRNewswire-First...ncedthatRandyScott,GenomicHealth,sExecutiveChairma...ConferenceinNewYorkCityonTuesday,December1,2009at1...chivedwebcastofthepresentation,visittheInvestorRel...estor.genomichealth.com .Pleaseconnecttothewebsite...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Cell...twillpresentatthe21stAnnualPiperJaffrayHealthCareC...attheNewYorkPalaceHotel. ,, CTIwillpresentonTue...loor).AliveaudiowebcastofCTI,spresentationwillbeav...eavailableforreplayafterwards. , ,PiperJaffrayHea...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2... Award Recognizes Leadership in Technology and Inn...., March 4 Lockheed Martin (NYSE: LMT ) has bee... of the Year" by Frost and Sullivan, recognizing t...ve biometrics solutions for a wide range of custom...ous analysis of the worldwide biometrics marketpla...
... , COLLEGE PARK, Md. There,s no "silver bullet" f... and acquisition policies, but they do need reform...fessor Jacques Gansler, who testified today before...directed the Defense Department,s acquisition oper...rved as a consultant for the Pentagon in interveni...
... Research into RNA, a molecule found in every cel... in the treatment of diseases such as cancer and d...ce Foundation was told. , The conference, held th...yra", CSIC in Granada, Spain, on 23 February 2009,...nt strategy for RNA research in Europe in recognit...
Other Biology News:Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan 2Reforming defense department acquisition policy: UM expert 2RNA research strategy for Europe takes shape 2...ists of universal lysis buffer, PCR mix, DNA polym...olume PCR reactions. This system can detect differ...cus bacteria, such as Escherichia Coli, Klebsiella...s, Streptococcus Agalactiae, and etc. With the pow...
...ect Cell Medium is optimized for serum-free growth... protein-free medium, Sf9 cultures routinely reach...ilities above 95%. This medium is also recommended...ng of pBACgus recombinants develops faster than ot...
GIBCO Grace's Insect Medium Supplemented (1X) liquid from Invitrogen
Virology LabFax from Promega
Biology Products: